LifeCare Alliance, Ohio State collaborate to advance cancer health equity

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Richard A. Rettig, the author of an authoritative history of the writing of the National Cancer Act of 1971, died on Aug. 7.

September 13, 2024

Vol.50 No.34

By Paul Goldberg

Clinical Trials & Tribulations

A simple intervention could help address overlooked pain among older adults with cancer in rural America

A recent article in JAMA Network Open published by myself and my research collaborators—Jill Harrison at Brown University, Sarah Yarborough at Fred Hutch, and Tammy Stokes at Maury Regional Medical Center—examined the potential for a brief communication-based intervention to help older adults with cancer who live in rural settings better manage their pain.

Mayo Clinic receives $50M from Stephen M. and Barbara J. Slaggie to expand cancer care access

Mayo Clinic received a $50 million investment from Stephen M. and Barbara J. Slaggie of Marco Island, FL, and Winona, MN.

September 13, 2024

Vol.50 No.34

In Brief

Carolyn Tucker receives President’s Lifetime Achievement Award

Carolyn M. Tucker, Ph.D., received a 2024 President’s Lifetime Achievement Award from the office of U.S. President Joe Biden. Photo credit: Carolyn TuckerCarolyn M. Tucker has received a 2024 President’s Lifetime Achievement Award from the office of President Joe Biden, in recognition of her work to build healthier communities and providing hundreds with power over cancer.

September 13, 2024

Vol.50 No.34

Clinical Roundup

DNA methylation contributes to 9/11-related breast cancers

A study led by researchers at NYU Langone Health and its Perlmutter Cancer Center has highlighted the role of DNA methylation in the increased risk of several cancers, including breast cancer, among rescuers and survivors of the attack on the World Trade Center on Sept. 11, 2001, in New York City.

September 13, 2024

Vol.50 No.34

Clinical Roundup

Mechanisms that clear mutations drive field cancerization in mammary tissue

A defensive mechanism responsible for normal remodeling of breast tissue during the menstrual cycle is a potential driver of breast cancer development, according to research by the Cancer Grand Challenges research team PRECISION.

September 13, 2024

Vol.50 No.34

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

YOU MAY BE INTERESTED IN

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

A simple intervention could help address overlooked pain among older adults with cancer in rural America

Mayo Clinic receives $50M from Stephen M. and Barbara J. Slaggie to expand cancer care access

Carolyn Tucker receives President’s Lifetime Achievement Award

DNA methylation contributes to 9/11-related breast cancers

Mechanisms that clear mutations drive field cancerization in mammary tissue

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login